New treatment for cancer 2019

Here are some new treatments for cancer that were approved or made significant progress in 2019:

  1. CAR-T Cell Therapy: The FDA approved two new CAR-T cell therapies, Kymriah (tisagenlecleucel) and Yescarta (axicabtagene ciloleucel), for certain types of blood cancers, including acute lymphoblastic leukemia (ALL) and diffuse large B-cell lymphoma (DLBCL).
  2. Lung Cancer Immunotherapy: The FDA approved a new immunotherapy, Tecentriq (atezolizumab), for patients with non-small cell lung cancer (NSCLC) who have progressed on other treatments.
  3. Breast Cancer Treatment: The FDA approved a new targeted therapy, Enhertu (fam-trastuzumab deruxtecan-nxki), for patients with HER2-positive breast cancer that has progressed on other treatments.
  4. Pancreatic Cancer Treatment: The FDA approved a new chemotherapy, Onivyde (irinotecan liposome injection), for patients with pancreatic cancer that has progressed on other treatments.
  5. Multiple Myeloma Treatment: The FDA approved a new immunotherapy, Empliciti (elotuzumab), for patients with multiple myeloma who have received at least two prior therapies.
  6. Gastric Cancer Treatment: The FDA approved a new chemotherapy, Zoladex (goserelin acetate), for patients with gastric cancer that has progressed on other treatments.
  7. Ovarian Cancer Treatment: The FDA approved a new targeted therapy, Rubraca (rucaparib), for patients with ovarian cancer that has progressed on other treatments.
  8. Prostate Cancer Treatment: The FDA approved a new immunotherapy, Erleada (apalutamide), for patients with non-metastatic castration-resistant prostate cancer.
  9. Melanoma Treatment: The FDA approved a new immunotherapy, Libtayo (cemiplimab-rwlc), for patients with advanced melanoma that has progressed on other treatments.
  10. Brain Cancer Treatment: The FDA approved a new chemotherapy, Lomustine (lomustine), for patients with glioblastoma, an aggressive form of brain cancer.

Some notable advancements in cancer research in 2019 include:

  1. Liquid Biopsies: Researchers made significant progress in developing liquid biopsies, which involve analyzing circulating tumor DNA (ctDNA) in blood or other bodily fluids to detect cancer.
  2. Cancer Vaccines: Researchers made progress in developing cancer vaccines, which aim to stimulate the immune system to attack cancer cells.
  3. Targeted Therapies: Researchers developed new targeted therapies that specifically target cancer-causing genes or proteins, leading to more effective and less toxic treatments.
  4. Immunotherapy Combinations: Researchers explored combining immunotherapies with other treatments, such as chemotherapy or targeted therapies, to enhance their effectiveness.

These are just a few examples of the many new treatments and advancements in cancer research that were made in 2019.